Zevra Therapeutics, Inc., a rare disease therapeutics company, appointed Adrian Quartel, chief medical officer. Quartel brings more than 20 years of experience in the international pharmaceutical industry with senior roles in clinical development, pharmacovigilance, and medical affairs. Quartel was previously the chief medical officer of Acer Therapeutics, where he played a key role in guiding clinical development, medical affairs, and regulatory compliance. Prior to that, he was the chief me...